Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Paracrine immunomodulation via mesenchymal stem cells (MSCs) refers to the process by which MSCs influence immune responses primarily through the secretion of soluble factors and extracellular vesicles, rather than direct cell-to-cell contact. This paracrine activity is a key mechanism underlying the therapeutic potential of MSCs in modulating both innate and adaptive immunity.
Modulates local/systemic immunity through secreted bioactive molecules without requiring direct cellular contact.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Paracrine Immunomodulation via Mesenchymal Stem Cells (MSC Paracrine Immunomodulation).